Pfizer Inc (PFE)
22.97
-1.32
(-5.43%)
USD |
NYSE |
Apr 04, 16:00
22.92
-0.05
(-0.22%)
After-Hours: 20:00
Pfizer Research and Development Expense (Quarterly): 3.035B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen Inc | 1.724B |
| Gilead Sciences Inc | 1.641B |
| Regeneron Pharmaceuticals Inc | 1.412B |
| Arvinas Inc | 83.30M |
| Moderna Inc | 1.122B |